Every year, people around the world take an astonishing 3.8 trillion doses of medicine. Most of these medicines are swallowed rather than injected or inhaled, because the oral route is the easiest, safest and most familiar ...
Nov 13, 2025
0
0
In cases of mild congenital heart defects, more prenatal visits are associated with a greater likelihood of appropriate delivery at a community hospital, according to a study published in JAMA Network Open. Results suggest ...
Nov 9, 2025
0
0
Risk prediction tools might help identify patients at the highest risk of overdose and death after a "before medically advised" (BMA) hospital discharge, according to new research in the Canadian Medical Association Journal.
Nov 11, 2025
0
0
Two U.S. Food and Drug Administration (FDA)-approved drugs for treating prostate cancer may also be effective against acute myeloid leukemia (AML), according to a new study by researchers at Penn State. AML, a cancer of blood ...
Nov 13, 2025
0
0
Two reviews published in The Lancet Obstetrics, Gynecology & Women's Health reveal stark global inequities in how endometriosis is recognized, treated, and prioritized in national health systems.
Nov 12, 2025
0
0
In the wake of a measles outbreak in Canada that has infected thousands of people over the past year, an international health agency revoked the country's measles-free status on Nov. 10, 2025.
Nov 10, 2025
0
0
A blocked coronary artery causing an acute heart attack must be opened immediately with a stent procedure. However, if other coronary arteries also appear to be narrowed, it is safe to wait and treat those later. This approach ...
Nov 13, 2025
0
21
Headache disorders affected almost 3 billion people worldwide in 2023—nearly one in every three people, a figure unchanged since 1990—and ranked sixth among causes of health loss, according to new research to be published ...
Nov 12, 2025
0
0
The malignant pediatric brain tumor medulloblastoma is driven by proteins deep within the cancer cells, for which there are often no effective drugs available. Researchers at Uppsala University have identified a new genetic ...
Nov 10, 2025
0
0
In a small, short duration trial (12 weeks), a new medication called DR10624 reduced triglyceride levels in most patients with severe hypertriglyceridemia by more than 60%, according to a preliminary late-breaking science ...
Nov 10, 2025
0
0
